Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
32 hedge funds and large institutions have $10.4M invested in Vyant Bio, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
248% more capital invested
Capital invested by funds: $2.99M → $10.4M (+$7.41M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
10% more funds holding
Funds holding: 29 → 32 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$330K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$280K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$223K |
| 4 |
BlackRock
New York
|
+$96.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$95.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$181K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$97K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$63.3K |
| 4 |
Squarepoint
New York
|
-$42K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $8K | – | – | – |
|
|
IA
27
IFP Advisors
Tampa,
Florida
| $8K | +$4.63K | +13 | New |
|
|
TDC
28
Thompson Davis & Co
Richmond,
Virginia
| $8K | +$4.63K | +13 | New |
|
|
CG
29
Cutler Group
San Francisco,
California
| $3K | -$1.42K | -4 | -40% |
|
30
Barclays
London,
United Kingdom
| $2K | – | – | – |
|
31
UBS Group
Zurich,
Switzerland
| $1K | -$1.07K | -3 | -60% |
|
|
SM
32
Sabby Management
Miami Beach,
Florida
| – | -$97K | -480 | Closed |
|
|
33
Squarepoint
New York
| – | -$42K | -206 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$25K | -122 | Closed |
|
|
TAM
35
Tocqueville Asset Management
New York
| – | -$20K | -100 | Closed |
|
36
Creative Planning
Overland Park,
Kansas
| – | -$5K | -27 | Closed |
|
VYNT Hedge Fund Activity: Q1 2017 in Review
32 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2017, worth a combined $10.4M — up 248% from $2.99M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VYNT positions and 6 closed out — a net gain of 6 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $330K. The largest seller was Jacobs Levy Equity Management, cutting an estimated $181K.
- 32 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2017, up from 29 in Q4 2016.
- Funds reported $10.4M of Vyant Bio, Inc. Common Stock stock for Q1 2017, up 248% quarter-over-quarter.
- 12 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2017 and 6 closed out, a net change of +6 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q1 2017 was Renaissance Technologies, an estimated $330K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q1 2017 was Jacobs Levy Equity Management, an estimated $181K sold.
Based on aggregated 13F filings for Q1 2017.